Hypofractionated RT

RADIATION3 trials

Sponsors

University of Chicago, Groupe Oncologie Radiotherapie Tete et Cou, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Conditions

CancerCarcinomaHead and Neck Squamous Cell CarcinomaLocally Advanced Pancreatic CancerMelanomaNonmetastatic Pancreatic CancerSarcomaTumor

Phase 1

Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

CompletedNCT01215500

University of ChicagoCancer, Carcinoma, Melanoma +2

Start: 2005-01-31End: 2018-03-31Updated: 2018-09-12

Phase 2

Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.

CompletedNCT02035072

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSLocally Advanced Pancreatic Cancer, Nonmetastatic Pancreatic Cancer, Unresectable Pancreatic Cancer

Start: 2010-11-30End: 2016-12-31Updated: 2017-07-21

Phase 3

Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC

CompletedNCT01864850

Groupe Oncologie Radiotherapie Tete et CouHead and Neck Squamous Cell Carcinoma

Start: 2013-10-18End: 2020-06-05Updated: 2023-09-22

Related Papers

Elderly Head and Neck Cancer (ELAN) study: Personalized treatment according to geriatric assessment in patients age 70 or older: First prospective trials in patients with squamous cell cancer of the head and neck (SCCHN) unsuitable for surgery.

Journal of Clinical Oncology2014-05-2019 citations